Abstract

The presented article provides research, analysis and discussion regarding the rationality and clinical effectiveness of topical antibacterial therapy for chronic nasopharyngitis after adenotomy, in particular the effectiveness of the drug Izofra. Thanks to the study, the effectiveness of the drug Izofra in the postoperative period was substantiated and analysed. The authors obtained valuable information, knowledge and experience thanks to a randomized sample study with the main and control groups, namely, confirmation of the pronounced anti-inflammatory, antibacterial effect of the drug Izofra and its objective rationality of use. Significant reduction of inflammation, reduction of edema, improvement of secretion rheology and increase of local immunity after use of the drug Izofra have been studied and analysed. The topical antibacterial, anti-inflammatory, anti-edematous effect and eradication of planktonic forms of microorganisms (biofilms) of the drug Izofra clinically demonstrated a decrease in the level of postoperative complications, chronicity of the process, relapses and improvement of the postoperative course of treatment of children.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call